Priority Date: 26.04.10 (US 20100328087P)

INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF CYSTEINYL-TRNA SYNTHETASE

  • Application ID: EP11777925
  • Status: EXAMINATION IN PROGRESS

Attorney

operating since 2006
Headquarter in Munich and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61, C07, and C12. Grund Intellectual Property Group is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 125 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 26.04.2010 - Priority Date (US 20100328087P)
  • 10.11.2011 - Publication A2 (WO2011139714)
  • 06.03.2013 - Publication A2 (EP2563380)